RU2004132205A - Комбинации эпинастина, белладонны и псевдоэфедрина в качестве новых фармацевтических составов - Google Patents

Комбинации эпинастина, белладонны и псевдоэфедрина в качестве новых фармацевтических составов Download PDF

Info

Publication number
RU2004132205A
RU2004132205A RU2004132205/15A RU2004132205A RU2004132205A RU 2004132205 A RU2004132205 A RU 2004132205A RU 2004132205/15 A RU2004132205/15 A RU 2004132205/15A RU 2004132205 A RU2004132205 A RU 2004132205A RU 2004132205 A RU2004132205 A RU 2004132205A
Authority
RU
Russia
Prior art keywords
pharmaceutically acceptable
acceptable salt
pseudoephedrine
oral administration
pharmaceutical composition
Prior art date
Application number
RU2004132205/15A
Other languages
English (en)
Russian (ru)
Inventor
СЕКО Норитака (JP)
СЕКО Норитака
Original Assignee
БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)
Берингер Ингельхайм Интернациональ Гмбх
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE), Берингер Ингельхайм Интернациональ Гмбх filed Critical БЕРИНГЕР ИНГЕЛЬХАЙМ ИНТЕРНАЦИОНАЛЬ ГмбХ (DE)
Publication of RU2004132205A publication Critical patent/RU2004132205A/ru

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/46—8-Azabicyclo [3.2.1] octane; Derivatives thereof, e.g. atropine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/02—Nasal agents, e.g. decongestants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/04—Antipruritics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/14—Decongestants or antiallergics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pulmonology (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Dermatology (AREA)
  • Otolaryngology (AREA)
  • Immunology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
RU2004132205/15A 2002-04-03 2003-03-28 Комбинации эпинастина, белладонны и псевдоэфедрина в качестве новых фармацевтических составов RU2004132205A (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02007568A EP1350512A1 (en) 2002-04-03 2002-04-03 Combinations of epinastine, belladonna and pseudoephedrine as new pharmaceutical formulations
EP02007568.5 2002-04-03

Publications (1)

Publication Number Publication Date
RU2004132205A true RU2004132205A (ru) 2005-09-10

Family

ID=27838061

Family Applications (1)

Application Number Title Priority Date Filing Date
RU2004132205/15A RU2004132205A (ru) 2002-04-03 2003-03-28 Комбинации эпинастина, белладонны и псевдоэфедрина в качестве новых фармацевтических составов

Country Status (12)

Country Link
US (1) US20030228359A1 (cg-RX-API-DMAC7.html)
EP (2) EP1350512A1 (cg-RX-API-DMAC7.html)
JP (1) JP2005522467A (cg-RX-API-DMAC7.html)
AR (1) AR039221A1 (cg-RX-API-DMAC7.html)
AU (1) AU2003221532A1 (cg-RX-API-DMAC7.html)
BR (1) BR0308982A (cg-RX-API-DMAC7.html)
CA (1) CA2477751A1 (cg-RX-API-DMAC7.html)
MX (1) MXPA04009582A (cg-RX-API-DMAC7.html)
PE (1) PE20040080A1 (cg-RX-API-DMAC7.html)
PL (1) PL371382A1 (cg-RX-API-DMAC7.html)
RU (1) RU2004132205A (cg-RX-API-DMAC7.html)
WO (1) WO2003082285A1 (cg-RX-API-DMAC7.html)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19954516A1 (de) * 1999-11-12 2001-05-17 Boehringer Ingelheim Int Epinastin-haltige Lösungen
US20030104017A1 (en) * 2001-10-26 2003-06-05 Boehringer Ingelheim International Gmbh Epinastine formulation for oral administration
KR20050092429A (ko) * 2003-01-22 2005-09-21 니찌방 가부시기가이샤 안질환 치료용 경피 흡수형 제제, 그 사용, 및 안질환치료약의 눈의 국소 조직으로의 이행 방법
JP2007517766A (ja) * 2003-09-24 2007-07-05 コンビナトアールエックス インコーポレーティッド 薬物の組み合わせを投与するための治療法
AU2005210086A1 (en) * 2004-02-06 2005-08-18 Meda Pharma Gmbh & Co. Kg Treatment of rhinitis with anticholinergics alone in combination with antihistamines phosphodiesterase 4 inhibitors, or corticosteroids
JP4936420B2 (ja) * 2005-08-02 2012-05-23 塩野義製薬株式会社 徐放性顆粒剤
JP5162141B2 (ja) * 2007-02-20 2013-03-13 エスエス製薬株式会社 フィルムコーティング用組成物
RU2366446C1 (ru) * 2008-06-27 2009-09-10 Сергей Анатольевич Небера Гомеопатическое средство для лечения конъюнктивитов
WO2010030418A1 (en) * 2008-09-10 2010-03-18 Micro-Dose Life Sciences Llc Anti-fever botanical composition and uses thereof
RU2567032C2 (ru) * 2009-05-01 2015-10-27 Апталис Фарматек, Инк. Перорально распадающиеся таблеточные композиции, содержащие комбинации неопиоидных и опиоидных анальгетиков
JP5852816B2 (ja) * 2010-09-10 2016-02-03 ロート製薬株式会社 液状医薬組成物、及びこれを含有する軟カプセル剤
RU2478377C1 (ru) * 2011-08-08 2013-04-10 Алексей Владимирович Брынцалов Комбинированный препарат орвиум для устранения симптомов простудных заболеваний и гриппа
CN110237079B (zh) * 2019-07-01 2021-05-14 山西大学 一种百部生物碱类似物的应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH10298107A (ja) * 1997-04-25 1998-11-10 Taisho Pharmaceut Co Ltd 医薬組成物
US6613357B2 (en) * 2000-01-13 2003-09-02 Osmotica Corp. Osmotic device containing pseudoephedrine and an H1 antagonist

Also Published As

Publication number Publication date
AR039221A1 (es) 2005-02-09
EP1350512A1 (en) 2003-10-08
PE20040080A1 (es) 2004-04-22
CA2477751A1 (en) 2003-10-09
PL371382A1 (en) 2005-06-13
AU2003221532A1 (en) 2003-10-13
MXPA04009582A (es) 2005-01-11
US20030228359A1 (en) 2003-12-11
WO2003082285A1 (en) 2003-10-09
BR0308982A (pt) 2005-01-04
JP2005522467A (ja) 2005-07-28
EP1492532A1 (en) 2005-01-05

Similar Documents

Publication Publication Date Title
RU2423106C2 (ru) Применение твердой пероральной дозировочной композиции пролонгированного действия для приготовления лекарственных средств
CN1119993C (zh) 醋氨酚、假麻黄碱、扑尔敏和可有可无的美沙芬的旋转制粒及包衣
CZ296964B6 (cs) Farmaceutické formulace tramadolu v násobných jednotkách a zpusob jejich výroby
JP2005512995A5 (cg-RX-API-DMAC7.html)
WO2010140111A1 (en) Pharmaceutical compositions containing a combination of an antihistamine and a decongestant
PL192075B1 (pl) Stabilna chemicznie kompozycja farmaceutyczna zawierająca dekarboetoksyloratadynę
JP2005522467A5 (cg-RX-API-DMAC7.html)
KR20040007756A (ko) 세티리진 및 슈도에페드린을 포함하는 정제
US20030228359A1 (en) Pharmaceutical formulations containing epinastine, belladonna, and pseudoephedrine
KR20090029314A (ko) 세티리진 및 슈도에페드린을 포함하는 정제
US10258617B2 (en) Dosing regimens for fast onset of antidepressant effect
US20050084527A1 (en) Pharmaceutical formulations containing combinations of epinastine, pseudoephedrine, and methylephedrine
US20100143471A1 (en) Novel reduced dose pharmaceutical compositions of fexofenadine and pseudoephedrine
CZ20004698A3 (cs) Lék pro podporu skončení nebo omezení kouření nebo prevence recidivy kouření
JP2005519053A (ja) 放出が改良された薬剤
CN104706639B (zh) 一种治疗雄性勃起功能障碍的药物组合物及其用途
KR101016832B1 (ko) 위장관 궤양의 치료를 위한 매스틱 함유 복합제제
US20230028539A1 (en) Pharmaceutical composition, complementary kit and application thereof
KR101199654B1 (ko) 안정한 서방출형의 경구 투여용 조성물
TWI292717B (en) Multiparticulate modified release composition
TWI243061B (en) Tablet comprising cetirizine and pseudoephedrine
Kulkarni 2) Patent Application Publication o Pub. No.: US 2010/0143471 A1
JP2010100550A (ja) 医薬組成物

Legal Events

Date Code Title Description
FA93 Acknowledgement of application withdrawn (no request for examination)

Effective date: 20060424